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Abstract
Infectious bovine rhinotracheitis (IBR) is a highly infectious disease of cattle caused by bovine herpesvirus 1
(BHV-1) that causes considerable economic losses to the dairy and beef industry. This report describes the results of
two surveys in which prevalence of serum antibodies against BHV-1 in Galicia (NW Spain) was determined. The first
was performed on the entire cattle population of the region (year 2000) and the second on the herds included in a
voluntary livestock health programme, which comprises IBR, conducted by a group of farms designated ADSG (Health
Defence Groups) in this same region (year 2004). Anti-BHV-1 antibodies were determined by anti-gB ELISA in serum
samples from all animals aged over one year in the area’s dairy and beef herds. Mean individual animal and herd
prevalence recorded in 2000 were 38.4% (ranging 37.3%-39.5%; 43.2% dairy, 26.8% beef) and 50.4% (ranging 46.4%-
54.4%; 58.3% dairy, 48.1% beef), respectively. Mean true prevalence by herd and animal for the ADSG farms were
47.2% (44.9%-49.5%; 51.5% dairy, 45.2% beef, 42.3% mixed) and 35.7% (35.3%-36.1%; 37.8% dairy, 33.1% beef,
25.5% mixed), respectively. However, the use of non-maker vaccines make difficult to develop a control and eradication
program based on serological analysis.
Additional key words: BHV-1, IBR, seroprevalence.
Resumen
Prevalencia de anticuerpos séricos frente al herpesvirus bovino tipo 1 en el ganado vacuno de Galicia 
(NO España)
La rinotraqueitis infecciosa bovina (IBR) es una enfermedad infecciosa del ganado producida por el herpesvirus
bovino tipo 1 (BHV-1) que causa considerables pérdidas económicas en la industria láctea y cárnica. Este artículo des-
cribe los resultados de dos estudios de prevalencia en los que se determina la presencia de anticuerpos frente al BHV-1
en Galicia (NO de España). El primero fue realizado sobre toda la población bovina de la región (año 2000) y el se-
gundo sobre los rebaños pertenecientes a las asociaciones de defensa sanitaria ganaderas (ADSG) en la misma región
(año 2004), que realizan un programa de vigilancia que incluye la IBR. La presencia de anticuerpos se determinó con
un ELISA anti-gB en las muestras de suero de todos los animales mayores de 1 año de los rebaños estudiados. Las
prevalencias medias por animal y por rebaño halladas en 2000 fueron 38,4% (intervalo 37,3%-39,5%; 43,2% en le-
che y 26,8% en carne) y 50,4% (intervalo 46,4%-54,4%; 58,3% en leche y 48,1% en carne) respectivamente. La pre-
valencia real media de rebaño y animal para las granjas de las ADSG fue de 47,2% (44,9%-49,5%; 51,5% en leche,
45,2% en carne y 42,3% en mixtas) y 35,7% (35,3%-36,1%; 37,8% en leche, 33,1% en carne y 25,5% en mixtas) res-
pectivamente. Sin embargo, el uso de vacunas no marcadoras dificulta el desarrollo de programas de control y erra-
dicación basados en el análisis serológico.
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Introduction
Infectious bovine rhinotracheitis (IBR) is a highly con-
tagious disease that affects cows worldwide, although
the different countries show very different prevalence.
Through eradication programmes, some European
Union (EU) countries or regions have managed to reach
the status of «IBR-free», and others are presently adopting
control or eradication programmes. A third group of coun-
tries, including Spain, have no official specific IBR pro-
gramme (Kramps et al., 2004; Borchers, 2006; Müller,
2006). Given that IBR appears in the World Organization
for Animal Health list of bovine diseases and that Euro-
pean countries vary greatly in their IBR status, restrictions
are now being imposed to the free circulation of animals
and their products among the countries of the EU.
Nowadays, there are two approaches in IBR control and
eradication in Europe (EFSA, 2006). The first line, used
in countries with an initial low prevalence (Denmark, Aus-
tria, Finland, Sweden, Switzerland and Norway) is a direct
test-slaughter policy. The second line, implemented in
countries with higher prevalence (Germany) began with
use of a marker vaccine to first reduce gB seroprevalence
and stop spreading of bovine herpes-virus-1 (BHV-1).
There are not data available that reflect the IBR
status of Galicia, Spain’s largest cattle population region.
Therefore, in 2000 a seroprevalence study to know the
infection status in this region was considered necessary.
After that, in Galicia in 2004, a voluntary sanitary
program was initiated in herds through Health Defense
Groups (ADSG in its Spanish Acronym). These herds
are committed to carry out a sanitary program that
includes the prohibition of conventional vaccines use
and its substitution for gE deleted (marker) vaccines,
as well as other sanitary measures and control programs
[cattle trade control, disinfection, decontamination and
bovine viral diarrhoea virus (BVDV), Johne’s disease
and neosporosis control].
The objective was to know the ADSG epidemiology
BHV-1 situation with the aim of establishing the bases
for the beginning of a control and eradication program.
Material and methods
Area description and herd selection
The northwest region of Spain, Galicia, is the country’s
largest bovine population region accounting for 16.8%
of Spain’s cattle, and milk and beef production quotas
that are on the rise, according to data obtained in 2000
(25.7% milk and 6.0% beef production) and 2004
(35.0% milk and 12.0% beef production). Spain has
no off icial IBR control programme and any control
measures in Galicia are voluntary campaigns undertaken
through the ADSGs, organisations set up in 2004. They
grouped initially 4.6% of the herds and 13.0% of Galician
bovine census. An annual increase in the number of the
ADSG took place until 2008 when they included 28.9%
of the total herds from Galicia and 36.0% of the census.
Control program against BHV-1 in ADSG involves
serological follow up of the farms, control of all
purchased animals and the ban of non-marker vaccines.
In 2000, an initial survey of the IBR situation from
Galicia’s entire cattle industry (36,481 dairy and 38,241
beef cattle farms) was performed. The sample size was
calculated based on a confidence level of 95%, a 5%
error and an expected prevalence (Pe) of 50.0%. Given
no previous epidemiological data for IBR in Galicia,
it was used the figure of 50.0% as the Pe despite the
need for a high sample size (Thrusf ield, 1995). No
mixed farms were included in this first survey since
these are not representative of the whole population.
Serum samples were obtained from all animals older
than 1 year in 375 dairy herds (6,038 animals) and 385
beef herds (2,690 animals). The mean herd size was 11.5
animals (16.1 for the dairy and 6.9 for the beef herds).
These herds were selected by stratified (dairy/beef)
random sampling according to the contribution of each
district to the total census for the region.
In the second survey performed in 2004 from farms
of the same region in all herds belonging to any ADSG,
serum samples were obtained from all animals over the
age of 1 year in 1,147 dairy herds (38,120 animals), 1,464
beef herds (21,219 animals) and 141 mixed dairy/beef
herds (2,504 animals). The mean herd size was 21.8
cows (33.2 dairy, 14.5 beef, 17.8 mixed). In this case,
mixed farms were included, since the aim was trying
to know the serologic profile in all the farms from ADSG.
To the 1,147 dairy herds analyzed in 2004, the vacci-
nation history of 584 was known, data provided by the
veterinarian in charge of the sanitary program for each
ADSG.
Diagnostic technique
BHV-1 antibodies were determined using a commer-
cial blocking ELISA test kit (Idexx HerdChek IBRgB)
that detects specif ic antibodies (sAb) against gB
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glycoprotein. This test detects serum antibodies both
from vaccine and real infection. The sensitivity (Se)
of the method is 95.4% and its specificity (Sp) is 99.0%
(Kramps et al., 2004). The controls and cutoff values
indicated by the manufacturer were used to score each
serum sample as negative (< 45% inhibition) or positive
(≥ 45% inhibition).
Statistical analysis
χ2-tests (packages SPSS 11.5 and Grahpad Instat)
were used to compare prevalences obtained by category
(dairy/beef), herd size, age of the animals and seropreva-
lence level according to intervals proposed by Pritchard
(2001): prevalence 0%, 0-5%, 5-20%, 20-60% and
> 60%). Results were considered significant when p ≤ 0.05.
True prevalences (TP) at the individual-animal level
were calculated as a function of Se, Sp and the apparent
prevalence (AP): TP = (AP + Sp – 1)/ (Se + Sp – 1)
(Noordhuizen et al., 1997). Likewise, true prevalence at
the herd level (HTP) was calculated as a function of herd
sensitivity (HSe), herd specificity (HSp) and apparent
herdlevel prevalence (HAP): HTP = (HAP + HSp – 1)/
(HSe + HSp 1). HSe and HSp values were calculated as
per Martin et al. (1992). Confidence intervals (CI) were
established using the equation described by Greiner
and Gardner (2000). Thus TP was used only as statistical
term, based on Se and Sp of the serological test.
Herds were declared positive if one or more animals
tested positive.
Results
Apparent and true prevalences are presented in Table 1.
The true prevalence were significantly higher for both
dairy herds and individual cows in dairy farms compared
to the beef cattle in the studies conducted in 2001 and
2004 (Table 1).
The vaccination status from 584 dairy herds in 2004
was known: 122 (20.9%) used vaccines while 462
(79.1%) did not vaccinate. It could be observed that
96.7% of the vaccinated herds were in groups of higher
prevalence (> 20%) whereas 80.7% of the non vaccinated
were in groups of prevalence ≤ 20% (Table 2).
When the herds were stratified by size, prevalence
for both dairy and beef herds in both surveys increased
significantly as the herd size increased (p < 0.0001 for
both categories and studies) (Table 3).
As the age of the animals increased, a signif icant
increase in the percentage of seropositive animals 
for BHV-1 (p < 0.0001) was recorded. In addition,
during the study conducted in 2004, signif icantly
lower seropositivity rates were obtained for the
animals 12-24 months (p < 0.0001) and 25-36 months
(p < 0.0001) of age than observed in 2000, yet this did
not occur in the group of animals aged > 36 months
(Table 4).
Separate analysis of the farms that have seropositive
animals from 12 to 24 months of age indicate that sero-
prevalence in this group is lower in 2004 (22.5%) than
in 2000 (26.6%) (Table 5).
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Table 1. Apparent (AP) and true (BHV-1) seroprevalence (TP) at the individual cow and herd level
Cattle Year
Herd-level (%) Animal-level (%)
AP TP (CI)a AP TP (CI)a
Dairy 2000 64.5 58.3 (52.6-64.0) 42.4 43.2 (41.9-44.5)
2004 65.3 51.5 (47.7-55.3) 36.9 37.8 (37.3-38.3)
Beef 2000 47.3 48.1  (42.2-54.0) 26.5 26.8 (25.0-28.6)
2004 52.7 45.2  (42.2-48.2) 32.4 33.1 (32.4-33.8)
Mixed 2004 51.8 42.3  (32.4-52.2) 25.3 25.5 (23.7-27.3)
Total 2000 55.8 50.4  (46.4-54.4) 37.5 38.4 (37.3-39.5)
2004 57.9 47.2  (44.9-49.5) 34.9 35.7 (35.3-36.1)
a CI: confidence intervals.
Table 2. Prevalences distribution of dairy herds according
with their vaccination status in 2004
Prevalence Vaccinated Non vaccinated
< 5% (2/284) 0.7% (282/284) 99.3%
5-20% (2/93) 2.2% (91/93) 97.8%
20-60% (10/67) 14.9% (57/67) 85.1%
> 60% (108/140) 77.1% (32/140) 22.9%
Total (122/584) 20.9% (462/584) 79.1%
Percentages of herds belonging to different prevalence
status showed that 44.2% and 42.1% of the farms in
2000 and 2004 respectively were BHV-1 free from
serological point of view (Table 6).
Discussion
Previous studies performed in Spain are poorly
representative of the real situation and are limited to
serological screening of small sample sizes or surveys
on small populations. Investigations on dairy herds
have established IBR prevalence in the range 17.3-
54.0% (Espuña et al., 1988; Prieto, 1991; Guitián, 2001).
The IBR status of countries in the european economic
area is highly variable. Studies established herd preva-
lence for Europe of 10-80%. After several decades of
eradication programmes, Finland, Norway, Sweden,
Austria, Denmark, Switzerland and the Bolzano region
of Italy, have been declared IBR-free by the OIE since
2003 (Borchers et al., 2006).
The prevalence obtained in this study for Galicia
region is similar or slightly lower to that observed in
the European countries that have not tried to control
IBR. These prevalences include 47.2% of beef cattle
in Portugal (Soares et al., 2006), 61.0% of the unvacci-
nated dairy herds of Italy (Cavinari, 2006), and 84.0%
of the dairy herds, 53.0% of the beef herds, 89.0% of
the mixed herds and 35.0%, 31.0% and 43.0% of the
dairy cows, beef cows and mixed dairy/beef animals
of Belgium (Boelaert et al., 2000). The same can be
said of the prevalences recorded at the start of eradi-
cation programmes such as the 50.0% for Germany
(Teuffer, 2006) or 80% for Hungary (Pálfi and Foldi,
2006).
The ELISA used cannot distinguish between sAb
induced by the conventional vaccine and those raised
against the field virus such that the seroprevalences
obtained are higher than true infection values (Nardelli
et al., 1999). Thus, an animal found seropositive for
BHV-1 may have been vaccinated or naturally infected
at some point, since the virus remains latent throughout
its lifetime and may be reactivated by factors causing
stress or immunosuppression (calving, corticosteroids,
overcrowding, transport, other illnesses, etc.) (Álvarez
et al., 2002; Ackermann and Engels, 2006; Muylkens
et al., 2007).
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Table 3. Individual-animal level BHV-1 seroprevalences (in percentages) stratified by sizes
Herd size (head)a
Dairy Beef Mixed Total
2000 2004 2000 2004 2004 2000 2004
1-9 45.0 40.7 38.4 32.0 27.5 40.7 32.8
10-17 70.2 53.1 73.3 57.0 67.6 71.5 56.2
18-29 76.1 63.3 70.0 77.5 55.6 74.6 69.9
> 29 92.3 76.6 100.0 89.2 73.1 93.1 78.7
a Four categories based on the quartiles of herd size.
Table 5. Percentage and number of farms with seropositive
animals younger than 24 months in both studies and aptitudes
Cattle 2000 (Galicia) 2004 (ADSG)a
Dairy (70/232) 30.2% (260/1040) 25.0%
Beef (37/171) 21.6% (180/916) 19.7%
Total (107/403) 26.6% (440/1956) 22.5%
a ADSG: Health Defence Groups.
Table 4. Individual-animal level IBR seroprevalences (in percentages) by age group
Age (months)a
Dairy Beef Total
2000 2004 2000 2004 2000 2004
12-24 29.2 21.1 15.4 19.6 25.8 20.8
25-36 40.7 30.6 16.5 25.3 35.1 29.3
> 36 43.4 42.3 27.9 33.6 38.3 38.9
a Three age groups were established; seropositives younger than 24 months were interpreted as re-
cent infections.
The known vaccination status of the 584 dairy farms
included in ADSG study meant that could determine
that the seroprevalence increased as the proportion of
vaccinated herds increased, supporting the idea that
the true prevalence of IBR in Galicia is lower than that
detected. Then, the success of a BHV-1 control program
depends on sttoping indiscriminate vaccination with
non marker vaccines that allows differenciate between
infection and vaccine antibodies. In fact, non marker
vaccines are nowadays biding in farms belonging to
ADSG in Galicia.
To this respect, a study carried out on foetus analyzed
in the Laboratory of Animal Health of Galicia during
the period from January to October 1999 (132 foetus
from dairy farms) conclude that there was a positive
direct immunofluorescence result for BHV-1 in 6.8%
of the cattle abortions investigated. However, isolation
of BHV-1 was not possible and there was always
another viral or bacterial agent involved (Mora et al.,
2000).
The higher prevalence observed for the dairy farms
in the present study could be attributable to the fact
that a farm was classif ied as positive for IBR when 
a single animal was scored as seropositive for the
BVH-1 virus. Given the significantly larger sizes of
the dairy herds, it was therefore more likely that 
an individual animal would be positive for the virus
(McDermott et al., 1997; Nardelli et al., 1999). Addi-
tionally, the larger dairy herds were subjected to more
extensive vaccination programmes, which lead to over-
reporting of seroprevalence figures since the ELISA
used in both studies fails to discriminate between the
vaccine and field virus (Nardelli et al., 1999).
Individual-animal prevalences were also higher for
the dairy compared to the beef herds for several reasons.
Intensive management and a higher density of dairy
cows (compared to the extensive or semi-extensive
management of beef or mixed cattle) promote viral
spreading and increase the chances that healthy suscep-
tible animals will come into contact with infected
animals (Guitián et al., 1998; Muylkens et al., 2007).
Further, in larger herds there is usually more movement
of animals (purchasing of replacement animals, etc.)
increasing the risk of infection (Solis-Calderón et al.,
2003), but also being more likely to have been vaccinated.
Our findings confirm the fact that herd size is a risk
factor for IBR seroprevalence (van Wuijckhuise et al.,
1998; Boelaert et al., 2005), but we cannot rule out it
is a confounding effect of vaccination.
Findings also indicate an increased proportion of
seropositive animals with increasing age. The older the
animal, the more likely it is that it will have been vacci-
nated or exposed to a natural infection source (Nardelli
et al., 1999; Solis-Calderón et al., 2003). Antibodies
against natural infection start to appear 8-10 days post-
infection and persist throughout the animal’s life
(Álvarez et al., 2000; Muylkens et al., 2007). Vaccine-
derived antibodies persist for several years (Van der
Poel et al., 1995; Nardelli et al., 1999).
Once obtained a serologic profile of the herds of the
ADSG, seronegative farms could be identified (42.1%).
On these, periodic controls in bulk tank milk and/or
the younger animal rearing group were done to detect
new infections.
The lower percentage of farms with seropositive
young heifers (12-24 months) in 2004 comparing to
2000 showed that measures established in the ADSG
seem to be efficient to get future long term eradication
of BHV-1.
Herds whose prevalences were < 5% could in the
short term become seronegatives by means of culling
seropositive animals and adequate biosecurity measures
to avoid new infections. Herds with higher prevalences
could besides include vaccination with gE deleted
vaccines so that in a determined period (according to
prevalence) they diminished the presence of infection
antibodies (Solís-Calderón et al., 2003; Franken,
2006).
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Table 6. Herd BHV-1 seroprevalence (in percentages) by herd prevalence status
Prevalence group
Dairy Beef Mixed Total
2000 2004 2000 2004 2004 2000 2004
0% 35.5 34.7 52.7 47.3 48.2 44.2 42.1
< 5% 3.5 9.5 0.5 3.8 7.1 2.0 6.3
5-20% 16.8 15.3 13.2 17.3 17.7 15.0 16.5
20-60% 17.6 12.4 18.7 11.8 11.3 18.2 12.0
> 60% 26.7 28.1 14.8 19.9 15.6 20.7 23.1
In conclusion the herds belonging to ADSG constitute
a suitable population for the beginning of IBR control
program, as much by their epidemiologic situation as
by the fact to be grouped in a defined geographic area,
that carry out a common sanitary program. To develop
a control program based on serological analysis biding
of non-maker vaccines would be necessary.
Acknowledgements
The authors thank the visiting veterinarians 
and those working at the Laboratorio de Sanidade e
Produción Animal de Galicia for their help in
collecting the serum samples, and their colleagues
from Seroloxía, ADSG and Campañas de Saneamento
Gandeiro for their help in processing and analysing
the samples. This study was supported by project
PGIDIT02RAG50701PR of the Xunta de Galicia.
References
ACKERMANN M., ENGELS M., 2006. Pro and contra IBR-
eradication. Vet Microbiol 113, 293-302.
ÁLVAREZ M., ARIAS P., 2000. Diagnóstico de laboratorio
de las infecciones por los virus de la diarrea vírica bovina
y de la rinotraqueitis bovina infecciosa. Producción
Animal 151, 3-20. [In Spanish].
ÁLVAREZ M., ARIAS P., VALDAZO B., 2002. Avances
recientes en las infecciones por pestivirus y herpesvirus
bovinos. Producción Animal 173, 26-36. [In Spanish].
BOELAERT F., BIRONT P., SOUMARE B., DISPAS M.,
VANOPDENBOSCH E., VERMEERSCH J.P., RASKIN
A., DUFEY J., BERKVENS D., KERKHOFS P., 2000.
Prevalence of bovine herpesvirus-1 in the Belgian cattle
population. Prev Vet Med 45, 285-295.
BOELAERT F., SPEYBROECK N., DE KRUIF A., AERTS
M.,  BURZYKOWSKI T. ,  MOLENBERGHS G. ,
BERKVENS D.L., 2005. Risk factors for bovine herpes-
virus 1 seropositivy. Prev Vet Med 69, 285-295.
BORCHERS K., 2006. BoHV-1 eradication: opening lecture.
Proc Symposium BHV-1 eradication, Berlin, Germany,
May 29-30. p. 4.
CAVINARI S., 2006. Epidemiological data on IBR in Italy
and experience of control in the field. Proc Symposium
BHV-1 eradication, Berlin, Germany, May 29-30. pp 8-9.
EFSA, 2006. Scientific report on a definition of a BHV-1-
free holding, and the procedures to verifity and maintain
this status (EFSA-Q-205-018).Annex to the EFSA Journal
311, 1-65.
ESPUÑA E., VENDRELL J., ARTIGAS C., 1988. IBR en
vacuno lechero. Estudio serológico de 1986 a 1988. Medi-
cina Veterinaria 5, 499-505. [In Spanish].
FRANKEN P., 2006. BHV-1 eradication: costs and benefits,
the Dutch experience. Proc Symposium BoHV-1 eradication,
Berlin, Germany, May 29-30. p. 13.
GREINER M., GARDNER I.A., 2000. Application of diag-
nostics tests in veterinary epidemiological studies. Prev
Vet Med 45, 43-59.
GUITIÁN F.J., 2001. Estudios observacionales de agentes
infecciosos asociados a ineficacia reproductiva en explo-
taciones de ganado vacuno lechero. Doctoral thesis. San-
tiago de Compostela University. Spain. [In Spanish].
GUITIÁN F.J., OLIVEIRA J., DONATE J., SANJUÁN M.L.,
YUS E., 1998. Estudio seroepidemiológico, a nivel de
explotación de las infecciones por herpesvirus bovino tipo
1 (BHV-1) en granjas lecheras de Asturias. Medicina
Veterinaria 15, 610-617. [In Spanish].
KRAMPS J.A., BANKS M., BEER M., KERKHOFS P.,
PERRIN M., WELLENBERG G.J., VAN OIRSCHOT
J.T., 2004. Evaluation of tests for antibodies against
bovine herpesvirus 1 performed in national reference
laboratories in Europe. Vet Microbiol 102, 169-181.
MARTIN S.W., SHOUKRI M., THORBURN M.A., 1992.
Evaluating the health status of herds based on tests applied
to individuals. Prev Vet Med 14, 33-43.
MCDERMOTT J.J., KADOHIRA M., O’CALLAGHAN
C.J., SHOUKRI M.M., 1997. A comparison of different
models for assesing variation in the seroprevalence of
infectious bovine rhinotracheitis by farm, area and district
in Kenya. Prev Vet Med 32, 219-234.
MORA A., MÉNDEZ A., LÓPEZ M., SECO B., ARNAIZ
I., VIGO T., FERNÁNDEZ D., EIRAS C., 2000. Diagnóstico
laboratorial de las causas de aborto en ganado vacuno en
Galicia. Laboratorio AVEDILA 13, 17-21. [In Spanish].
MÜLLER K.E., 2006. Clinical symptoms in cattle suffering
from BHV-1 infections. Proc Symposium BHV-1
eradication, Berlin, Germany, May 29-30. p. 5.
MUYLKENS B., THIRY J., KIRTEN P., SCHYNTS F.,
THIRY E., 2007. Bovine herpesvirus 1 infection and
infectious bovine rhinotracheitis. Vet Res 38, 181-209.
NARDELLI S., MARANGON S., DALLA POZA M.,
PONZONI A., VIEL L., BRICHESE M., 1999. Bovine
herpesvirus 1 (BHV-1) seroprevalence in the breeding
cattle population of the Veneto region: prospects for the
implementation of a control programme. J Vet Med B 46,
735-740.
NOORDHUIZEN J.P.T.M., FRANKENA K., VAN DER
HOOFD C.M., GRAAF E.A.M., 1997. Measurement of
disease frequency. In: Application of quantitative methods
in veterinary epidemiology, 1st ed. (Noordhuizen J.P.T.M.,
Frankena K., Van der Hoofd C.M., Graaf E.A.M., eds).
Wageningen Pers. pp 63-97.
PÁLFI V., FÖLDI J., 2006. Experiences on BHV-1 eradi-
cation in Hungary. Proc Symposium BHV-1 eradication,
Berlin, Germany, May 29-30. p. 15.
PRITCHARD G., 2001. Milk antibodies testing in cattle.
Farm Practice 23, 542-549.
PRIETO J.M., 1991. Causas infecciosas de aborto en el
ganado vacuno de Asturias. In: El herpesvirus bovino 1 y
el virus de la diarrea vírica bovina-enfermedad de las
BHV-1 seroprevalence 805
mucosas, como causas de problemas reproductivos en los
bovinos. Doctoral thesis. León University. [In Spanish].
SOARES L., SANTOS F., TAVARES E., LOPES J.C., BRITO
N.V., 2006. Estudio sanitario del vacuno del Alto Miño:
la incidencia de IBR y BVD. Proc XIV Congreso Inter-
nacional de la Federación Mediterránea de Sanidad 
y Producción de Rumiantes, Lugo, Spain, July 12-15. 
p. 107.
SOLÍS-CALDERÓN J.J. ,  SEGURA-CORREA V.M.,
SEGURA-CORREA J.C., ALVARADO-ISLAS A., 2003.
Seroprevalence of and risk factors for infectious bovine
rhinotracheitis in beef cattle herds of Yucatán, Mexico.
Prev Vet Med 57, 199-208.
TEUFFERT J., 2006. The national IBR/IPV- eradication
program in Germany. Achievements and problems. Proc
Symposium BHV-1 eradication, Berlin, Germany, May
29-30. p. 14.
THRUSFIELD M., 1995. Surveys. In: Veterinary epidemiology,
2nd edn (Thrusf ield M., ed). Blackwell Science Ltd,
Oxford. pp. 178-197.
VAN DER POEL W.H.M., KRAMPS J.A., QUAK J.,
BRAND A., VAN OIRSCHOT J.T., 1995. Persistence of
bovine herpesvirus-1 specific antibodies in cattle after
intranasal vaccination with a live virus vaccine. Vet Rec
137, 347-348.
VAN WUIJCKHUISE L., BOSCH J., FRANKEN P.,
FRANKENA K., ELBERS A.R.W., 1998. Epidemiological
characteristics of bovine herpesvirus 1 infection deter-
mined by bulk milk testing of all Dutch dairy herds. Vet
Rec 142, 181-184.
806 C. Eiras et al. / Span J Agric Res (2009) 7(4), 0-0
